nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.337	1	CbGbCtD
Zolpidem—Major depression—Riluzole—amyotrophic lateral sclerosis	0.014	0.0263	CcSEcCtD
Zolpidem—Tetany—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0218	CcSEcCtD
Zolpidem—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.0101	0.019	CcSEcCtD
Zolpidem—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.0101	0.019	CcSEcCtD
Zolpidem—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.0099	0.0187	CcSEcCtD
Zolpidem—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00952	0.018	CcSEcCtD
Zolpidem—Yawning—Riluzole—amyotrophic lateral sclerosis	0.00934	0.0176	CcSEcCtD
Zolpidem—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00917	0.0173	CcSEcCtD
Zolpidem—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.00885	0.0167	CcSEcCtD
Zolpidem—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.0087	0.0164	CcSEcCtD
Zolpidem—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00802	0.0151	CcSEcCtD
Zolpidem—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00767	0.0145	CcSEcCtD
Zolpidem—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00756	0.0143	CcSEcCtD
Zolpidem—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.00716	0.0135	CcSEcCtD
Zolpidem—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00716	0.0135	CcSEcCtD
Zolpidem—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00688	0.013	CcSEcCtD
Zolpidem—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00663	0.0125	CcSEcCtD
Zolpidem—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00557	0.0105	CcSEcCtD
Zolpidem—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00552	0.0104	CcSEcCtD
Zolpidem—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00537	0.0101	CcSEcCtD
Zolpidem—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00532	0.01	CcSEcCtD
Zolpidem—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00532	0.01	CcSEcCtD
Zolpidem—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00527	0.00993	CcSEcCtD
Zolpidem—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00522	0.00984	CcSEcCtD
Zolpidem—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00522	0.00984	CcSEcCtD
Zolpidem—Mania—Riluzole—amyotrophic lateral sclerosis	0.00517	0.00976	CcSEcCtD
Zolpidem—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00504	0.0095	CcSEcCtD
Zolpidem—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00504	0.0095	CcSEcCtD
Zolpidem—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.005	0.00942	CcSEcCtD
Zolpidem—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.005	0.00942	CcSEcCtD
Zolpidem—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.005	0.00942	CcSEcCtD
Zolpidem—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00897	CcSEcCtD
Zolpidem—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00431	0.00813	CcSEcCtD
Zolpidem—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00414	0.0078	CcSEcCtD
Zolpidem—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00411	0.00775	CcSEcCtD
Zolpidem—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00765	CcSEcCtD
Zolpidem—Gout—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0076	CcSEcCtD
Zolpidem—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00398	0.0075	CcSEcCtD
Zolpidem—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00398	0.0075	CcSEcCtD
Zolpidem—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00386	0.00727	CcSEcCtD
Zolpidem—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00718	CcSEcCtD
Zolpidem—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0071	CcSEcCtD
Zolpidem—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0071	CcSEcCtD
Zolpidem—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0071	CcSEcCtD
Zolpidem—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0071	CcSEcCtD
Zolpidem—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00701	CcSEcCtD
Zolpidem—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00685	CcSEcCtD
Zolpidem—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00685	CcSEcCtD
Zolpidem—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00652	CcSEcCtD
Zolpidem—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00335	0.0666	CbGeAlD
Zolpidem—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00632	CcSEcCtD
Zolpidem—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00616	CcSEcCtD
Zolpidem—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00323	0.0061	CcSEcCtD
Zolpidem—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00604	CcSEcCtD
Zolpidem—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00598	CcSEcCtD
Zolpidem—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00592	CcSEcCtD
Zolpidem—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00306	0.0609	CbGeAlD
Zolpidem—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00576	CcSEcCtD
Zolpidem—Injury—Riluzole—amyotrophic lateral sclerosis	0.00297	0.0056	CcSEcCtD
Zolpidem—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00296	0.0588	CbGeAlD
Zolpidem—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00555	CcSEcCtD
Zolpidem—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00548	CcSEcCtD
Zolpidem—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00548	CcSEcCtD
Zolpidem—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00541	CcSEcCtD
Zolpidem—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00534	CcSEcCtD
Zolpidem—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00532	CcSEcCtD
Zolpidem—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00281	0.0053	CcSEcCtD
Zolpidem—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00515	CcSEcCtD
Zolpidem—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00515	CcSEcCtD
Zolpidem—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00511	CcSEcCtD
Zolpidem—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00507	CcSEcCtD
Zolpidem—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00507	CcSEcCtD
Zolpidem—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00497	CcSEcCtD
Zolpidem—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0049	CcSEcCtD
Zolpidem—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00488	CcSEcCtD
Zolpidem—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00484	CcSEcCtD
Zolpidem—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00249	0.0047	CcSEcCtD
Zolpidem—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00465	CcSEcCtD
Zolpidem—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00464	CcSEcCtD
Zolpidem—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00456	CcSEcCtD
Zolpidem—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00454	CcSEcCtD
Zolpidem—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00454	CcSEcCtD
Zolpidem—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00445	CcSEcCtD
Zolpidem—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00445	CcSEcCtD
Zolpidem—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00434	CcSEcCtD
Zolpidem—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00428	CcSEcCtD
Zolpidem—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00427	CcSEcCtD
Zolpidem—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00416	CcSEcCtD
Zolpidem—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00411	CcSEcCtD
Zolpidem—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00217	0.0041	CcSEcCtD
Zolpidem—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00406	CcSEcCtD
Zolpidem—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00403	CcSEcCtD
Zolpidem—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00399	CcSEcCtD
Zolpidem—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00397	CcSEcCtD
Zolpidem—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00397	CcSEcCtD
Zolpidem—Depression—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00396	CcSEcCtD
Zolpidem—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00391	CcSEcCtD
Zolpidem—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00389	CcSEcCtD
Zolpidem—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00389	CcSEcCtD
Zolpidem—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00387	CcSEcCtD
Zolpidem—Tolmetin—PTGS2—amyotrophic lateral sclerosis	0.00205	1	CrCbGaD
Zolpidem—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00386	CcSEcCtD
Zolpidem—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00374	CcSEcCtD
Zolpidem—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00372	CcSEcCtD
Zolpidem—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00192	0.0382	CbGeAlD
Zolpidem—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00357	CcSEcCtD
Zolpidem—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00355	CcSEcCtD
Zolpidem—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00355	CcSEcCtD
Zolpidem—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00354	CcSEcCtD
Zolpidem—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00352	CcSEcCtD
Zolpidem—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0035	CcSEcCtD
Zolpidem—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00349	CcSEcCtD
Zolpidem—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00333	CcSEcCtD
Zolpidem—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00175	0.0349	CbGeAlD
Zolpidem—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00331	CcSEcCtD
Zolpidem—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00321	CcSEcCtD
Zolpidem—GABRA1—brainstem—amyotrophic lateral sclerosis	0.0017	0.0337	CbGeAlD
Zolpidem—Chills—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0032	CcSEcCtD
Zolpidem—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00318	CcSEcCtD
Zolpidem—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00312	CcSEcCtD
Zolpidem—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0031	CcSEcCtD
Zolpidem—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00306	CcSEcCtD
Zolpidem—Tension—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00304	CcSEcCtD
Zolpidem—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00304	CcSEcCtD
Zolpidem—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00301	CcSEcCtD
Zolpidem—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00159	0.003	CcSEcCtD
Zolpidem—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00298	CcSEcCtD
Zolpidem—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00291	CcSEcCtD
Zolpidem—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00288	CcSEcCtD
Zolpidem—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00287	CcSEcCtD
Zolpidem—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00285	CcSEcCtD
Zolpidem—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00283	CcSEcCtD
Zolpidem—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0028	CcSEcCtD
Zolpidem—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00279	CcSEcCtD
Zolpidem—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00278	CcSEcCtD
Zolpidem—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00278	CcSEcCtD
Zolpidem—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00274	CcSEcCtD
Zolpidem—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00273	CcSEcCtD
Zolpidem—Cough—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00271	CcSEcCtD
Zolpidem—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00268	CcSEcCtD
Zolpidem—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00264	CcSEcCtD
Zolpidem—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00264	CcSEcCtD
Zolpidem—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00264	CcSEcCtD
Zolpidem—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00263	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00262	CcSEcCtD
Zolpidem—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00261	CcSEcCtD
Zolpidem—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00258	CcSEcCtD
Zolpidem—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00255	CcSEcCtD
Zolpidem—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00253	CcSEcCtD
Zolpidem—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00253	CcSEcCtD
Zolpidem—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00134	0.0266	CbGeAlD
Zolpidem—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00134	0.0266	CbGeAlD
Zolpidem—Infection—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00251	CcSEcCtD
Zolpidem—Shock—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00249	CcSEcCtD
Zolpidem—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00248	CcSEcCtD
Zolpidem—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00247	CcSEcCtD
Zolpidem—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00246	CcSEcCtD
Zolpidem—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00245	CcSEcCtD
Zolpidem—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.0013	0.0258	CbGeAlD
Zolpidem—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00241	CcSEcCtD
Zolpidem—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00237	CcSEcCtD
Zolpidem—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00123	0.0245	CbGeAlD
Zolpidem—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00231	CcSEcCtD
Zolpidem—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00229	CcSEcCtD
Zolpidem—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00227	CcSEcCtD
Zolpidem—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00226	CcSEcCtD
Zolpidem—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00119	0.0237	CbGeAlD
Zolpidem—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00119	0.0237	CbGeAlD
Zolpidem—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00225	CcSEcCtD
Zolpidem—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00119	0.0236	CbGeAlD
Zolpidem—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00118	0.0235	CbGeAlD
Zolpidem—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00223	CcSEcCtD
Zolpidem—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0022	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00219	CcSEcCtD
Zolpidem—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00218	CcSEcCtD
Zolpidem—Pain—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00216	CcSEcCtD
Zolpidem—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00216	CcSEcCtD
Zolpidem—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00209	CcSEcCtD
Zolpidem—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00207	CcSEcCtD
Zolpidem—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00201	CcSEcCtD
Zolpidem—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00106	0.002	CcSEcCtD
Zolpidem—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00106	0.002	CcSEcCtD
Zolpidem—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00105	0.021	CbGeAlD
Zolpidem—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00103	0.0204	CbGeAlD
Zolpidem—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00101	0.02	CbGeAlD
Zolpidem—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00101	0.02	CbGeAlD
Zolpidem—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000989	0.00187	CcSEcCtD
Zolpidem—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.000969	0.0193	CbGeAlD
Zolpidem—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.000969	0.0193	CbGeAlD
Zolpidem—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000963	0.00182	CcSEcCtD
Zolpidem—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00095	0.00179	CcSEcCtD
Zolpidem—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.000947	0.0188	CbGeAlD
Zolpidem—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.000947	0.0188	CbGeAlD
Zolpidem—GABRA3—brain—amyotrophic lateral sclerosis	0.000943	0.0188	CbGeAlD
Zolpidem—GABRA2—nervous system—amyotrophic lateral sclerosis	0.000919	0.0183	CbGeAlD
Zolpidem—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000919	0.00173	CcSEcCtD
Zolpidem—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.000917	0.0182	CbGeAlD
Zolpidem—GABRA1—nervous system—amyotrophic lateral sclerosis	0.000888	0.0177	CbGeAlD
Zolpidem—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000888	0.00167	CcSEcCtD
Zolpidem—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.000885	0.0176	CbGeAlD
Zolpidem—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.000865	0.0172	CbGeAlD
Zolpidem—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.000855	0.017	CbGeAlD
Zolpidem—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000854	0.00161	CcSEcCtD
Zolpidem—Rash—Riluzole—amyotrophic lateral sclerosis	0.000846	0.0016	CcSEcCtD
Zolpidem—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000846	0.00159	CcSEcCtD
Zolpidem—Headache—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00159	CcSEcCtD
Zolpidem—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.000836	0.0166	CbGeAlD
Zolpidem—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000797	0.0015	CcSEcCtD
Zolpidem—GABRB3—nervous system—amyotrophic lateral sclerosis	0.000773	0.0154	CbGeAlD
Zolpidem—GABRG2—brain—amyotrophic lateral sclerosis	0.000769	0.0153	CbGeAlD
Zolpidem—GABRB2—brain—amyotrophic lateral sclerosis	0.000769	0.0153	CbGeAlD
Zolpidem—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.000744	0.0148	CbGeAlD
Zolpidem—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000743	0.0148	CbGeAlD
Zolpidem—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.000727	0.0145	CbGeAlD
Zolpidem—GABRA2—brain—amyotrophic lateral sclerosis	0.000703	0.014	CbGeAlD
Zolpidem—GABRA1—brain—amyotrophic lateral sclerosis	0.000679	0.0135	CbGeAlD
Zolpidem—GABRB3—brain—amyotrophic lateral sclerosis	0.000591	0.0117	CbGeAlD
Zolpidem—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000562	0.0112	CbGeAlD
Zolpidem—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000474	0.00941	CbGeAlD
Zolpidem—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000456	0.00906	CbGeAlD
Zolpidem—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000396	0.00786	CbGeAlD
Zolpidem—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000389	0.00774	CbGeAlD
Zolpidem—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000381	0.00757	CbGeAlD
Zolpidem—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000375	0.00745	CbGeAlD
Zolpidem—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000366	0.00728	CbGeAlD
Zolpidem—PTGS1—brain—amyotrophic lateral sclerosis	0.000362	0.0072	CbGeAlD
Zolpidem—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000305	0.00382	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000304	0.00381	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000302	0.00378	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0003	0.00376	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000299	0.00374	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000298	0.00373	CbGpPWpGaD
Zolpidem—CYP2D6—brain—amyotrophic lateral sclerosis	0.000298	0.00591	CbGeAlD
Zolpidem—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000297	0.00372	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000295	0.00369	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000295	0.00369	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000292	0.00365	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000289	0.00362	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000286	0.00358	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000286	0.00358	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000281	0.00352	CbGpPWpGaD
Zolpidem—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00028	0.0035	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000276	0.00346	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000275	0.00344	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000274	0.00343	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000274	0.00343	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000271	0.00339	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00027	0.00337	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000269	0.00337	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000267	0.00334	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000266	0.00333	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000261	0.00327	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000261	0.00327	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000258	0.00322	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000258	0.00322	CbGpPWpGaD
Zolpidem—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000257	0.00322	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000257	0.00322	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000257	0.00322	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000257	0.00321	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000255	0.00319	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000255	0.00319	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000255	0.00319	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000252	0.00315	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000251	0.00314	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000251	0.00314	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000251	0.00313	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000246	0.00308	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000244	0.00306	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000243	0.00304	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000236	0.00295	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000233	0.00292	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000229	0.00287	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000228	0.00285	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000226	0.00283	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000224	0.0028	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000223	0.0028	CbGpPWpGaD
Zolpidem—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00022	0.00275	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000219	0.00274	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000219	0.00274	CbGpPWpGaD
Zolpidem—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000218	0.00273	CbGpPWpGaD
Zolpidem—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000215	0.00269	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000215	0.00269	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000213	0.00266	CbGpPWpGaD
Zolpidem—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000201	0.00251	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000199	0.00249	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000195	0.00244	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000183	0.00229	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000182	0.00227	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00018	0.00226	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000173	0.00217	CbGpPWpGaD
Zolpidem—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000171	0.00214	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000165	0.00207	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000162	0.00203	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000161	0.00202	CbGpPWpGaD
Zolpidem—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000159	0.002	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000159	0.00198	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000157	0.00197	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000155	0.00194	CbGpPWpGaD
Zolpidem—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000155	0.00193	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000153	0.00192	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000147	0.00184	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000147	0.00184	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000146	0.00182	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000141	0.00176	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000141	0.00176	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00014	0.00175	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00014	0.00175	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000139	0.00173	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000138	0.00173	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000138	0.00173	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000137	0.00172	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000137	0.00172	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000137	0.00171	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000135	0.00169	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000135	0.00169	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000131	0.00164	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00013	0.00163	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000128	0.0016	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000125	0.00157	CbGpPWpGaD
Zolpidem—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000124	0.00155	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000123	0.00154	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000123	0.00153	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000122	0.00153	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000122	0.00153	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000122	0.00153	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00012	0.0015	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00012	0.0015	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000119	0.00149	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000119	0.00149	CbGpPWpGaD
Zolpidem—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000119	0.00148	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000118	0.00148	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000118	0.00148	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000118	0.00147	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000118	0.00147	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000115	0.00144	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000114	0.00142	CbGpPWpGaD
Zolpidem—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000113	0.00142	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000112	0.0014	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000112	0.0014	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000112	0.0014	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00011	0.00138	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000109	0.00137	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000108	0.00136	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000105	0.00131	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000104	0.0013	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000103	0.00129	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000102	0.00127	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000101	0.00126	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	9.77e-05	0.00122	CbGpPWpGaD
Zolpidem—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	9.67e-05	0.00121	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.55e-05	0.00119	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	9.47e-05	0.00118	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	9.02e-05	0.00113	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.91e-05	0.00111	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	8.83e-05	0.00111	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	8.83e-05	0.00111	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	8.83e-05	0.00111	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.79e-05	0.0011	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	8.56e-05	0.00107	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.4e-05	0.00105	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.2e-05	0.00103	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	8.14e-05	0.00102	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.13e-05	0.00102	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.08e-05	0.00101	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	8.08e-05	0.00101	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.01e-05	0.001	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.66e-05	0.000958	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	7.65e-05	0.000957	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.51e-05	0.00094	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	7.06e-05	0.000883	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.94e-05	0.000869	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.85e-05	0.000857	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	6.83e-05	0.000854	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	6.83e-05	0.000854	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	6.7e-05	0.000838	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.55e-05	0.000819	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.49e-05	0.000812	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	6.39e-05	0.000799	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.37e-05	0.000797	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	6.28e-05	0.000786	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	6.28e-05	0.000786	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	6.25e-05	0.000781	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	6.23e-05	0.000779	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	6.23e-05	0.000779	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	6.18e-05	0.000773	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	5.99e-05	0.000749	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.81e-05	0.000726	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.81e-05	0.000726	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	5.74e-05	0.000719	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	5.69e-05	0.000712	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	5.46e-05	0.000683	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.45e-05	0.000682	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.36e-05	0.00067	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.34e-05	0.000668	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	5.32e-05	0.000666	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	5.32e-05	0.000666	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.29e-05	0.000662	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.29e-05	0.000661	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	5.07e-05	0.000635	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	5.02e-05	0.000628	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	4.98e-05	0.000623	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.96e-05	0.000621	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	4.94e-05	0.000618	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.92e-05	0.000615	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	4.87e-05	0.000609	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	4.84e-05	0.000605	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	4.54e-05	0.000568	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.52e-05	0.000566	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	4.5e-05	0.000563	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.49e-05	0.000561	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	4.47e-05	0.000559	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	4.25e-05	0.000532	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	4.11e-05	0.000514	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	4.11e-05	0.000514	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	3.85e-05	0.000481	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	3.76e-05	0.00047	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	3.74e-05	0.000468	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	3.67e-05	0.000459	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.49e-05	0.000437	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	3.45e-05	0.000432	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.44e-05	0.000431	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	3.41e-05	0.000427	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.28e-05	0.000411	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	3.18e-05	0.000397	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	3.15e-05	0.000394	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.14e-05	0.000393	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.07e-05	0.000385	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.97e-05	0.000371	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.92e-05	0.000365	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.87e-05	0.000359	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.84e-05	0.000355	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.73e-05	0.000341	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.69e-05	0.000337	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.64e-05	0.000331	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.61e-05	0.000326	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.59e-05	0.000324	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.59e-05	0.000323	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.51e-05	0.000314	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.45e-05	0.000307	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.43e-05	0.000304	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.36e-05	0.000295	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.25e-05	0.000281	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.21e-05	0.000276	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.08e-05	0.00026	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	2.06e-05	0.000258	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.02e-05	0.000252	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	2e-05	0.00025	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.97e-05	0.000247	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.81e-05	0.000227	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.77e-05	0.000222	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.71e-05	0.000213	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.62e-05	0.000202	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.52e-05	0.000191	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.49e-05	0.000186	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.41e-05	0.000177	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.4e-05	0.000175	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.4e-05	0.000175	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.39e-05	0.000174	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.38e-05	0.000173	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.37e-05	0.000171	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.29e-05	0.000161	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.28e-05	0.00016	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.19e-05	0.000149	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.15e-05	0.000144	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000137	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.06e-05	0.000133	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.05e-05	0.000131	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.02e-05	0.000128	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.16e-06	0.000115	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	8.98e-06	0.000112	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.42e-06	0.000105	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.9e-06	9.88e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.26e-06	9.09e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.2e-06	9.01e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	6.93e-06	8.67e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.15e-06	7.7e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.75e-06	5.94e-05	CbGpPWpGaD
